CLBT Price Prediction Next Week
Technical Analysis
CLBT's stock has shown significant volatility, dropping 19% following its latest full-year results. The stock is currently trading at $19.46, showing signs of recovery with a post-market increase of 1.78%. The recent price action forms a potential support level around $18.93.
Fundamental Analysis Recent earnings report revealed:
- Revenue of $401M, meeting analyst expectations
- Forecast revenue growth of 21% for 2025, outpacing industry average of 12%
- Analysts have upgraded EPS estimates to $0.27 for 2025
Analyst Consensus
- Strong Buy rating with average price target raised to $28.00
- Price target range: $26.00 - $30.00
- Craig-Hallum maintains Buy rating with analyst consensus showing strong confidence
Price Prediction for Next Week Based on technical indicators and recent fundamental developments:
- Support level: $18.93
- Resistance level: $20.50
- Expected trading range: $19.00 - $21.00
Target price for next week: $20.75
Recommendation: BUY Rationale:
- Strong analyst upgrades
- Above-industry growth expectations
- Recent price correction provides attractive entry point
- Positive momentum in post-market trading
- Clear revenue growth visibility with 21% projected increase
The stock shows potential for upward movement given the recent correction and strong fundamental outlook. The current price level presents a favorable risk-reward ratio for entering long positions.
CLBT Similar Chart Price Prediction
The price of CLBT is predicted to go up 1.64%, based on the high correlation periods with PSEC. The similarity of these two price pattern on the periods is 96.37%.
CLBT
PSEC
Up: 1.64%Similarity: 96.37%
CLBT Revenue Forecast
CLBT EPS Forecast
CLBT FAQs
What is bull’s view on CLBT?
What is bear's view on CLBT?
What is CLBT revenue forecast for next quarter？
What is CLBT eps forecast for next quarter？
CLBT Analyst's Forecast
Brian Essex
JP Morgan
Buy
2025-02-11
Price Target
$24 → $28
Upside
+15.7%
JPMorgan analyst Brian Essex raised the firm's price target on Cellebrite to $28 from $24 and keeps an Overweight rating on the shares as part of a Q4 earnings preview for the security software group. The firm thinks growth will continue to accelerate for Cellebrite and expects its ongoing platform expansion, deeper government penetration, and migration to its subscription platform will result in better long-term fundamental strength.
Jeff Van Rhee
Craig-Hallum
Strong Buy
2024-09-25
Price Target
$20 → $23
Upside
+38.35%
Shaul Eyal
TD Cowen
Strong Buy
2024-09-23
Price Target
$20 → $23
Upside
+32.95%
